Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-08-03 to 2022-08-24
Current total value of award: $34063.68
Description: 4558010732!TYSABRI 300 MG/15 ML VIAL 15ML